Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 327

1.

Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.

Park SS, Yan D, McGrath S, Dilworth JT, Liang J, Ye H, Krauss DJ, Martinez AA, Kestin LL.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):947-52. doi: 10.1016/j.ijrobp.2011.08.025. Epub 2011 Dec 28.

PMID:
22208964
2.

A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.

Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):400-8.

PMID:
15667959
3.

Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.

Vesprini D, Catton C, Jacks L, Lockwood G, Rosewall T, Bayley A, Chung P, Gospodarowicz M, Ménard C, Milosevic M, Nichol A, Skala M, Warde P, Bristow RG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):608-16. doi: 10.1016/j.ijrobp.2011.07.019. Epub 2011 Nov 16.

PMID:
22099034
4.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, Gustafson G, Ye H, Martinez A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):204-12. doi: 10.1016/j.ijrobp.2010.10.009. Epub 2010 Dec 16.

PMID:
21167653
5.

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):965-73.

PMID:
15989996
6.

Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.

Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9.

PMID:
16111582
7.

Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.

Deville C, Both S, Bui V, Hwang WT, Tan KS, Schaer M, Tochner Z, Vapiwala N.

Radiat Oncol. 2012 May 23;7:76. doi: 10.1186/1748-717X-7-76.

8.

Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Bohrer M, Schröder P, Welzel G, Wertz H, Lohr F, Wenz F, Mai SK.

Strahlenther Onkol. 2008 Dec;184(12):674-8. doi: 10.1007/s00066-008-1837-z. Epub 2008 Dec 24.

PMID:
19107349
9.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
10.

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.

Patel N, Faria S, Cury F, David M, Duclos M, Shenouda G, Ruo R, Souhami L.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):534-9. doi: 10.1016/j.ijrobp.2013.02.010. Epub 2013 Apr 15.

PMID:
23597418
11.

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34.

PMID:
15752881
12.

Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers.

Engels B, Soete G, Verellen D, Storme G.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):388-91. doi: 10.1016/j.ijrobp.2008.08.007. Epub 2008 Dec 4.

PMID:
19056185
13.

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, Carver B, Coleman J, Lovelock M, Hunt M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9. doi: 10.1016/j.ijrobp.2011.11.047. Epub 2012 Feb 11.

PMID:
22330997
14.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. Review.

PMID:
16029785
15.

An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.

Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):289-302.

PMID:
10925000
16.

Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.

Adkison JB, McHaffie DR, Bentzen SM, Patel RR, Khuntia D, Petereit DG, Hong TS, Tomé W, Ritter MA.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):184-90. doi: 10.1016/j.ijrobp.2010.09.018. Epub 2010 Dec 14.

17.

A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity.

Norkus D, Miller A, Kurtinaitis J, Haverkamp U, Popov S, Prott FJ, Valuckas KP.

Strahlenther Onkol. 2009 Nov;185(11):715-21. doi: 10.1007/s00066-009-1982-z. Epub 2009 Nov 10.

PMID:
19899003
19.

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.

Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant WH 3rd, Lu HH, Woo SY, Carpenter LS, Chiu JK, Butler EB.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):705-12.

PMID:
11172952
20.

Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.

Vesprini D, Sia M, Lockwood G, Moseley D, Rosewall T, Bayley A, Bristow R, Chung P, Ménard C, Milosevic M, Warde P, Catton C.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e415-21. doi: 10.1016/j.ijrobp.2011.01.024. Epub 2011 Apr 7.

PMID:
21477939
Items per page

Supplemental Content

Write to the Help Desk